Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 521-540
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Harshit Agarwal Investor at Morgan Stanley | Mumbai, India | Corporate VCPrivate equity | FinTechHardware | View profile | |
 Yarden Sheffi Financial Storyteller at Teva Pharmaceuticals | Tel Aviv-Yafo, Israel | Corporate VC | Healthcare | View profile | |
 Alexander Belcredi Managing Director at BioNTech SE | Vienna, Austria | Corporate VCVenture capital | AIHealthcare | View profile | |
 Joori Yoo Affiliated at Ebest | Seoul, South Korea | Private equityVenture debt | AIHealthcare | View profile | |
 Evgeny Zaytsev Investor at Bering Capital | San Francisco, United States | Venture capital | Healthcare | View profile | |
 Mudit Thaperr Co-Founder Mahanidhi Enterprises at SUN PHARMA | India | Corporate VC | Healthcare | View profile | |
 Jakob Ravn Hansen Principal at BioInnovation Institute (BII) | Copenhagen, Denmark | Accelerator | ClimateFood | View profile | |
 Maria Vardanyan Investor at Morgan Stanley | United States | Corporate VCPrivate equity | FinTechHardware | View profile | |
 Borbála Tünde Baranyi Kiss Director, Inclusive and Sustainable Ventures at Morgan Stanley | Hungary | Corporate VCPrivate equity | FinTechHardware | View profile | |
 Eglantine Rollet Investor at Pulsalys | Lyon, France | Accelerator | Healthcare | View profile | |
 Jonny Crowther Founder in Residence at Entrepreneurs First | San Francisco, United States | AcceleratorVenture capital | AIHardware | View profile | |
 Remi Janicot Biotech Venture Capital at Nextech Invest | Boston, United States | Venture capital | Healthcare | View profile | |
 Jonathan Chan Partner at Wilson Sonsini Goodrich & Rosati | San Francisco, United States | Corporate VC | AIClimate | View profile | |
 Miri K. Venture Capitalist at SBI Investment | Japan | Private equityVenture capital | AIHardware | View profile | |
 Zed Ni Investor at Fosun Pharma | Shanghai, China | Corporate VC | AIHealthcare | View profile | |
 Antonia Zoric Venture Program Manager - Biolnnovation Institute at BioInnovation Institute (BII) | Copenhagen, Denmark | Accelerator | ClimateFood | View profile | |
 Frederick Schlimmer Investor at Lombard Odier Group | Zürich, Switzerland | Family Office | ClimateFinTech | View profile | |
 Noriyuki Ito Venture Capitalist at SBI Investment | Minato, Japan | Private equityVenture capital | AIHardware | View profile | |
 Travis Fleming Life Science Investor at 5AM Ventures | San Francisco, United States | Venture capital | Healthcare | View profile | |
 Jeff Stevens Post Graduate Student in AASCB Bridge Degree Program at University of Florida Graduate School | Lake Charles, United States | Government-backed | Healthcare | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal